Market Leads & Opportunities
United Kingdom-Edinburgh: Anagrelide, Ezetimibe, Ivabradine & Rosuvastatin – Framework Lead
The current contract for Anagrelide, Ezetimibe, Ivabradine & Rosuvastatin – Framework Lead is projected to end on 12-OCT-19 and may be available for retender. Anagrelide, Ezetimibe, Ivabradine & Rosuvastatin
Anagrelide, Ezetimibe, Ivabradine & Rosuvastatin
This framework is for the supply of Anagrelide, Ezetimibe, Ivabradine & Rosuvastatin tablets to health boards across NHS Scotland.
The Authority intends awarding a single-supplier framework agreement on a line by line basis. Full details can be found within the ITT.
This framework is for the supply of Anagrelide, Ezetimibe, Ivabradine & Rosuvastatin tablets to health boards across NHS Scotland.
The Authority intends awarding a single-supplier framework agreement on a line by line basis. Full details can be found within the ITT.
Common procurement vocabulary (CPV): 33600000, Pharmaceutical products,
More Market Leads
- Committee to decide on more than 100 homes in Somerset
26 Feb 25
Plans for more than 100 homes in Somerset will go before committee today (25 February). - Funding for Argyll and Bute housing projects
26 Feb 25
The UK Government has committed to delivering a package of support from the CRP to Argyll and Bute Council totalling £20.34 million. - Lead developer sought for city centre redevelopment
26 Feb 25
Hull City Council says it has taken a step forward on its redevelopment of the former BHS building in the city centre.
- In association with::
